van der Ven, E. et al. Ethnoracial risk variation across the psychosis continuum in the US: a systematic review and meta-analysis. JAMA Psychiatry 81, 447–455 (2024).
International Schizophrenia, Consortium et al. Common polygenic variation contributes to risk of schizophrenia and bipolar disorder. Nature 460, 748–752 (2009).
de Candia, T. R. et al. Additive genetic variation in schizophrenia risk is shared by populations of African and European descent. Am. J. Hum. Genet. 93, 463–470 (2013).
Lam, M. et al. Comparative genetic architectures of schizophrenia in East Asian and European populations. Nat. Genet. 51, 1670–1678 (2019).
Peterson, R. E. et al. Genome-wide association studies in ancestrally diverse populations: opportunities, methods, pitfalls, and recommendations. Cell 179, 589–603 (2019).
Gaziano, J. M. et al. Million Veteran Program: a mega-biobank to study genetic influences on health and disease. J. Clin. Epidemiol. 70, 214–223 (2016).
Ding, Y. et al. Polygenic scoring accuracy varies across the genetic ancestry continuum. Nature 618, 774–781 (2023).
Bigdeli, T. B. et al. Penetrance and pleiotropy of polygenic risk scores for schizophrenia, bipolar disorder, and depression among adults in the US Veterans Affairs health care system. JAMA Psychiatry 79, 1092–1101 (2022).
Harvey, P. D. et al. The genetics of functional disability in schizophrenia and bipolar illness: methods and initial results for VA cooperative study #572. Am. J. Med. Genet. B. Neuropsychiatr. Genet. 165B, 381–389 (2014).
The All of Us Research Program Investigators. The “All of Us” Research Program. N. Engl. J. Med. 381, 668–676 (2019).
Trubetskoy, V. et al. Mapping genomic loci implicates genes and synaptic biology in schizophrenia. Nature 604, 502–508 (2022).
Nanou, E. & Catterall, W. A. Calcium channels, synaptic plasticity, and neuropsychiatric disease. Neuron 98, 466–481 (2018).
Dean, C. et al. Neurexin mediates the assembly of presynaptic terminals. Nat. Neurosci. 6, 708–716 (2003).
Celestino-Soper, P. B. S. et al. A common X-linked inborn error of carnitine biosynthesis may be a risk factor for nondysmorphic autism. Proc. Natl Acad. Sci. USA 109, 7974–7981 (2012).
Zou, Y., Carbonetto, P., Wang, G. & Stephens, M. Fine-mapping from summary data with the “Sum of Single Effects” model. PLoS Genet. 18, e1010299 (2022).
Gao, B. & Zhou, X. MESuSiE enables scalable and powerful multi-ancestry fine-mapping of causal variants in genome-wide association studies. Nat. Genet. 56, 170–179 (2024).
Yuan, K. et al. Fine-mapping across diverse ancestries drives the discovery of putative causal variants underlying human complex traits and diseases. Nat. Genet. 56, 1841–1850 (2024).
Peyrot, W. J. & Price, A. L. Identifying loci with different allele frequencies among cases of eight psychiatric disorders using CC-GWAS. Nat. Genet. 53, 445–454 (2021).
Atkinson, E. G. et al. Tractor uses local ancestry to enable the inclusion of admixed individuals in GWAS and to boost power. Nat. Genet. 53, 195–204 (2021).
Kachuri, L. et al. Principles and methods for transferring polygenic risk scores across global populations. Nat. Rev. Genet. 25, 8–25 (2024).
Zhu, K. et al. Multi-omic profiling of the developing human cerebral cortex at the single-cell level. Sci. Adv. 9, eadg3754 (2023).
Clarence, T. et al. Multiomic single-cell profiling identifies critical regulators of postnatal brain. Nat. Genet. 57, 591–603 (2025).
Fullard, J. F. et al. Population-scale cross-disorder atlas of the human prefrontal cortex at single-cell resolution. Sci. Data 12, 954 (2025).
Lee, D. et al. Single-cell atlas of transcriptomic vulnerability across brain disorders. Nature (in the press).
Zhang, M. J. et al. Polygenic enrichment distinguishes disease associations of individual cells in single-cell RNA-seq data. Nat. Genet. 54, 1572–1580 (2022).
Venkatesh, S. et al. Single-nucleus transcriptome-wide association study of human brain disorders. Preprint at medRxiv https://doi.org/10.1101/2024.11.04.24316495 (2024).
Cano-Gamez, E. & Trynka, G. From GWAS to function: using functional genomics to identify the mechanisms underlying complex diseases. Front. Genet. 11, 424 (2020).
Mostafavi, H., Spence, J. P., Naqvi, S. & Pritchard, J. K. Systematic differences in discovery of genetic effects on gene expression and complex traits. Nat. Genet. 55, 1866–1875 (2023).
Fulco, C. P. et al. Activity-by-contact model of enhancer-promoter regulation from thousands of CRISPR perturbations. Nat. Genet. 51, 1664–1669 (2019).
Nasser, J. et al. Genome-wide enhancer maps link risk variants to disease genes. Nature 593, 238–243 (2021).
Cochet-Bissuel, M., Lory, P. & Monteil, A. The sodium leak channel, NALCN, in health and disease. Front. Cell. Neurosci. 8, 132 (2014).
Wang, K.-S., Liu, X.-F. & Aragam, N. A genome-wide meta-analysis identifies novel loci associated with schizophrenia and bipolar disorder. Schizophr. Res. 124, 192–199 (2010).
Ots, H. D., Tracz, J. A., Vinokuroff, K. E. & Musto, A. E. CD40–CD40L in neurological disease. Int. J. Mol. Sci. 23, 4115 (2022).
Roussos, P. et al. Convergent findings for abnormalities of the NF-κB signaling pathway in schizophrenia. Neuropsychopharmacology 38, 533–539 (2013).
Zheutlin, A. B. et al. Penetrance and pleiotropy of polygenic risk scores for schizophrenia in 106,160 patients across four health care systems. Am. J. Psychiatry 176, 846–855 (2019).
Bigdeli, T. B. et al. Contributions of common genetic variants to risk of schizophrenia among individuals of African and Latino ancestry. Mol. Psychiatry 25, 2455–2467 (2020).
Bigdeli, T. B. et al. Genome-wide association studies of schizophrenia and bipolar disorder in a diverse cohort of US veterans. Schizophr. Bull. 47, 517–529 (2021).
Stevenson, A. et al. Neuropsychiatric Genetics of African Populations-Psychosis (NeuroGAP-Psychosis): a case-control study protocol and GWAS in Ethiopia, Kenya, South Africa and Uganda. BMJ Open 9, e025469 (2019).
Roberts, T. et al. INTREPID II: protocol for a multistudy programme of research on untreated psychosis in India, Nigeria and Trinidad. BMJ Open 10, e039004 (2020).
Bruxel, E. M. et al. Psychiatric genetics in the diverse landscape of Latin American populations. Nat. Genet. 57, 1074–1088 (2025).
Holla, B. et al. A cross ancestry genetic study of psychiatric disorders from India. Preprint at medRxiv https://doi.org/10.1101/2024.04.25.24306377 (2024).
Gitik, M., Bingaman, L. A., Rowland, L. M. & Marques, A. H. The NIMH supports more comprehensive and inclusive genomic studies in psychiatry. World Psychiatry 23, 292–293 (2024).
Koopmans, F. et al. SynGO: an evidence-based, expert-curated knowledge base for the synapse. Neuron 103, 217–234 (2019).
Shi, J. et al. Common variants on chromosome 6p22.1 are associated with schizophrenia. Nature 460, 753–757 (2009).
Calkins, M. E. et al. The Consortium on the Genetics of Endophenotypes in Schizophrenia: model recruitment, assessment, and endophenotyping methods for a multisite collaboration. Schizophr. Bull. 33, 33–48 (2007).
Hunter-Zinck, H. et al. Genotyping array design and data quality control in the Million Veteran Program. Am. J. Hum. Genet. 106, 535–548 (2020).
The All of Us Research Program Genomics Investigators. Genomic data in the All of Us Research Program. Nature 627, 340–346 (2024).
Chang, C. C. et al. Second-generation PLINK: rising to the challenge of larger and richer datasets. Gigascience 4, 7 (2015).
Willer, C. J., Li, Y. & Abecasis, G. R. METAL: fast and efficient meta-analysis of genomewide association scans. Bioinformatics 26, 2190–2191 (2010).
Han, B. & Eskin, E. Random-effects model aimed at discovering associations in meta-analysis of genome-wide association studies. Am. J. Hum. Genet. 88, 586–598 (2011).
Yang, J. et al. Conditional and joint multiple-SNP analysis of GWAS summary statistics identifies additional variants influencing complex traits. Nat. Genet. 44, 369–375 (2012).
Yang, J., Lee, S. H., Goddard, M. E. & Visscher, P. M. GCTA: a tool for genome-wide complex trait analysis. Am. J. Hum. Genet. 88, 76–82 (2011).
CONVERGE consortium. Sparse whole-genome sequencing identifies two loci for major depressive disorder. Nature 523, 588–591 (2015).
Maples, B. K., Gravel, S., Kenny, E. E. & Bustamante, C. D. RFMix: a discriminative modeling approach for rapid and robust local-ancestry inference. Am. J. Hum. Genet. 93, 278–288 (2013).
de Leeuw, C. A., Mooij, J. M., Heskes, T. & Posthuma, D. MAGMA: generalized gene-set analysis of GWAS data. PLoS Comput. Biol. 11, e1004219 (2015).
Barbeira, A. N. et al. Exploring the phenotypic consequences of tissue specific gene expression variation inferred from GWAS summary statistics. Nat. Commun. 9, 1825 (2018).
Lee, S. H. et al. Estimating the proportion of variation in susceptibility to schizophrenia captured by common SNPs. Nat. Genet. 44, 247–250 (2012).
Berner, D. Allele frequency difference AFD–an intuitive alternative to FST for quantifying genetic population differentiation. Genes 10, 308 (2019).
Ge, T., Chen, C.-Y., Ni, Y., Feng, Y.-C. A. & Smoller, J. W. Polygenic prediction via Bayesian regression and continuous shrinkage priors. Nat. Commun. 10, 1776 (2019).
Denny, J. C. et al. PheWAS: demonstrating the feasibility of a phenome-wide scan to discover gene–disease associations. Bioinformatics 26, 1205–1210 (2010).
Genovese G. et al. BCFtools/liftover: an accurate and comprehensive tool to convert genetic variants across genome assemblies. Bioinformatics 40, btae038 (2024).
